Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Hemic or immune system
Reexamination Certificate
2006-05-26
2010-06-29
Belyavskyi, Michail A (Department: 1644)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Hemic or immune system
C435S372000, C530S300000
Reexamination Certificate
active
07744927
ABSTRACT:
The present invention provides methods, improved cell culture medium and kits for promoting hematopoietic and mesenchymal stem and lineage-specific cell proliferation and differentiation by growth in the presence of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2type 2 receptor agonists, either alone or in combination with other growth factors and cytokines.
REFERENCES:
patent: 5015629 (1991-05-01), diZerega
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5629292 (1997-05-01), Rodgers et al.
patent: 5693616 (1997-12-01), Krstenansky et al.
patent: 5716935 (1998-02-01), Rodgers et al.
patent: 5834432 (1998-11-01), Rodgers et al.
patent: 5955430 (1999-09-01), Rodgers et al.
patent: 6096709 (2000-08-01), Rodgers et al.
patent: 6110895 (2000-08-01), Rodgers et al.
patent: 6165978 (2000-12-01), Rodgers et al.
patent: 6177407 (2001-01-01), Rodgers et al.
patent: 6239109 (2001-05-01), Rodgers et al.
patent: 6248587 (2001-06-01), Rodgers et al.
patent: 6258778 (2001-07-01), Rodgers et al.
patent: 6335195 (2002-01-01), Rodgers et al.
patent: 6444646 (2002-09-01), Rodgers et al.
patent: 6455500 (2002-09-01), Rodgers et al.
patent: 6475988 (2002-11-01), Rodgers et al.
patent: 6482800 (2002-11-01), Rodgers et al.
patent: 6498138 (2002-12-01), Rodgers et al.
patent: 6566335 (2003-05-01), Rodgers et al.
patent: 6730775 (2004-05-01), Rodgers et al.
patent: 6747008 (2004-06-01), Rodgers et al.
patent: 6762167 (2004-07-01), Rodgers et al.
patent: 6821953 (2004-11-01), Rodgers et al.
patent: 6916783 (2005-07-01), Rodgers et al.
patent: 7118748 (2006-10-01), Rodgers et al.
patent: 7173011 (2007-02-01), Rodgers et al.
patent: 7338938 (2008-03-01), Rodgers et al.
patent: 2003/0130196 (2003-07-01), Rodgers et al.
patent: 2004/0006003 (2004-01-01), Rodgers et al.
patent: 2005/0004036 (2005-01-01), Rodgers et al.
patent: 2005/0032688 (2005-02-01), Rodgers et al.
patent: 2005/0187163 (2005-08-01), Rodgers et al.
patent: 2005/0277595 (2005-12-01), Rodgers et al.
patent: 2008/0039363 (2008-02-01), diZerega et al.
patent: 2008/0167252 (2008-07-01), diZerega et al.
patent: 2009/0069246 (2009-03-01), Rodgers et al.
patent: WO 95/08337 (1985-03-01), None
patent: WO 95/08565 (1995-03-01), None
patent: WO 96/14858 (1996-05-01), None
patent: WO 96/39164 (1996-12-01), None
patent: WO 97/34627 (1997-09-01), None
Feldman et al ., Transplant. Proc. 1998, 30, 4126-4127.
Cochlovius et al., Modern Drug Discovery, 2003, pp. 33-38.
Rodgers et al., Histologic alterations in dermal repair after thermal injury effects of topical angiotensin II.J. Burn Care Rehabil. 18:381-388 (1997).
DeCherney et al., Expression of cyclin protein after thermal skin injury in a guinea pig model.J. Burn Care Rehabil. 18:292-298 (1997).
Hunt, T.K. et al., Coagulation and macrophage stimulation of angiogenesis and wound healing. In The surgical wound, pp. 1-18, ed. F. Dineen & G. Hildrick-Smith (Lea & Febiger, Philadelphia: 1981).
Kunapuli and Kumar, Molecular cloning of human angiotensinogen cDNA and evidence for the presence of its mRNA in rat heart.Circulation Research60:786-790 (1987).
Clouston et al., Molecular cloning of the mouse angiotensinogen gene.Genomics2:240-248 (1988).
Kageyama et al., Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence.Biochemistry23:3603-3609 (1984).
Ohkubo et al., Cloning and sequence analysis of cDNA for rat angiotensinogen.Proc. Natl. Acad. Sci. 80:2196-2200 (1983).
Berk et. al., Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells.Hypertension13:305-14 (1989).
Kawahara, et al., Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells.BBRC150:52-9 (1988).
Naftilan, et al., Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.J. Clin. Invest. 83:1419-23 (1989).
Taubman et al., Angiotensin II induces c-fos mRNA in aortic smooth muscle.J. Biol. Chem. 264:526-530 (1989).
Nakahara, et al., Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II.BBRC184:811-8 (1992).
Stouffer and Owens, Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor beta.Circ. Res. 70:820 (1992).
Wolf, et al., Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells.Am. J. Pathol. 140:95-107 (1992).
Bell and Madri, Influence of the angiotensin system on endothelial and smooth muscle cell migration.Am. J. Pathol. 137:7-12 (1990).
Fernandez, et al., Neovascularization produced by angiotensin II.J. Lab. Clin. Med. 105:141 (1985).
LeNoble, et al., Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo.Eur. J. Pharmacol. 195:305-6 (1991).
Powell, et al., Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.Science245:186-8 (1989).
Powell, et al., The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition.J. Cardiovasc. Pharmacol. 16:S42-9 (1991).
Capron, et al., Effect of ramipril, an inhibitor of angiotensin converting enzyme, on the response of rat thoracic aorta to injury with a balloon catheter.J. Cardiovasc. Pharmacol. 18:207-11 (1991).
Osterriedes, et al., Role of angiotensin II in injury-induced neointima formation in rats.Hypertension18(Supp) II60-64 (1991).
Daemen et al., Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.Circ. Res. 68:450-6 (1991).
Schelling, et al., Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells.J. Cell. Physiol. 98:503-14 (1979).
Campbell-Boswell and Robertson, Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro.Exp. Mol. Pathol. 35:265-76 (1981).
Paquet, et al., Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats.J. Hyperten. 8:565-72 (1990).
Naftilan, The role of angiotensin II in vascular smooth muscle cell growth.J. Cardiovas. Pharmacol. 20:S37-40 (1992).
Gibbons, et al., Vascular smooth muscle cell hypertrophy vs. hyperplasia.J. Clin. Inv. 90:456-61 (1992).
Bell, et al., Autcrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-srcexpression.J. Clin. Inv. 89:315-20 (1992).
Wolf, et al., Intracellular signaling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells.Cell. Reg. 2:219-27 (1991).
Zhou, et al., Angiotensin II-mediated stimulation of collagen synthesis in cultured cardiac fibroblasts.FASEB. J. 6:A1914 (5661) (1992).
Pfeilschifter, et al., Angiotensin II stimulation of phospholipase D in rat renal mesangial cells is mediated by the AT1 receptor subtype.Eur. J. Pharmacol. 225:57-62 (1992).
Jaiswal, et al., Stimulation of endothelial cell prostaglandin production by angiotensin peptides.Hypertension19(Supp. II):II-49-II-55 (1992).
Edwards and Stack, Angiotensin II inhibits glomerular adenylate cyclase via the angiotensin II receptor subtype 1.J. Pharmacol. Exper. Ther. 266:506-510 (1993).
Jaiswal, et al., Differential regulation of prostaglandin synthesis by angiotensin peptides in aortic smooth muscle cells: Subtypes of angiotensin receptors involved.J. Pharmacol. Exper. Ther. 265:664-673 (1991).
Jaiswal, et al., Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes.Hypertension17:1115-1120 (1991).
Portsi, et al., Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin
diZerega Gere
Rodgers Kathleen
Belyavskyi Michail A
McDonnell Boehnen & Hulbert & Berghoff LLP
University of Southern California
LandOfFree
Methods of promoting hematopoietic and mesenchymal cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of promoting hematopoietic and mesenchymal cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of promoting hematopoietic and mesenchymal cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4173486